Biopharma

Novo Nordisk offers cheaper Wegovy for all cash-paying ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering al...

Academic medical centers say funding cuts jeopardize he...

Proposed cuts to National Institutes of Health funding threaten innovation neces...

Biogen plots 2028 headquarters shift to new 'innovation...

Biogen on Monday said it signed a 15-year lease for a building at Cambridge’s Ke...

STAT+: Pharmalittle: We’re reading about 23andMe bankru...

23andMe plans to file for bankruptcy and CEO and co-founder Anne Wojcicki will d...

The Service Edge: The Key to Unlocking the Full Potenti...

Biopharma moves fast—your data solutions provider should too. Learn how excellen...

Rethinking Direct-to-Consumer Audiences: The Case for A...

Generate up to 6x more script lift. An adaptive, dynamic approach optimizes DTC ...

Revolutionizing Patient Marketing: How PatientPoint Pre...

PatientPoint Precision is reshaping patient marketing by combining EHR data with...

The closest hospital vs. the one people actually delive...

In today's Morning Rounds newsletter, proposed cuts to cancer research under the...

STAT+: 23andMe filing for bankruptcy as CEO Anne Wojcic...

23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne...

STAT+: 23andMe files for bankruptcy as CEO Anne Wojcick...

23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne...

QRD Form 2 and checklist for the submission of day +25 ...

QRD Form 2 and checklist for the submission of day +25 files - veterinary

Agenda of the CHMP meeting 24-27 March 2025

Agenda of the CHMP meeting 24-27 March 2025

Minutes of the CAT meeting 4-6 December 2024

Minutes of the CAT meeting 4-6 December 2024

Annex to 24-27 March 2025 CHMP Agenda

Annex to 24-27 March 2025 CHMP Agenda

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya ...

Pilot on advice from expert panels to manufacturers of ...

Pilot on advice from expert panels to manufacturers of high-risk medical devices...

Leveraging clinical and financial data sets to guide in...

Understanding private sector breakthroughs, acquisitions and funding is critical...

Accelerate oncology drug development: A data-driven app...

Speed vs. success in oncology trials: Discover data-driven strategies to acceler...

Opinion: Five years ago, early career researchers neede...

A generation of scientists and their future work will be lost if the U.S. doesn’...

Lawmakers are pushing the HALT Fentanyl Act as the solu...

The bill targets fentanyl-related substances, but illegally manufactured fentany...

Opinion: STAT+: Philanthropy can help create a healthie...

Small biotech companies are the heart of drug innovation, but they need help. Ph...

STAT+: Cancer research, long protected, feels ‘devastat...

Cancer research has had bipartisan support. But Trump administration budget cuts...

Pensions risk: the downside of weight-loss drugs

The health benefits could be so extreme that it upends the annuity market, hitti...

Novartis Receives Third FDA Approval for Oral Fabhalta ...

Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.